Asymmetric Dimethylarginine and Cardiovascular Risk: Systematic Review and Meta-Analysis of 22 Prospective Studies

BACKGROUND: Asymmetric dimethylarginine (ADMA) inhibits the production of nitric oxide, a key regulator of the vascular tone, and may be important in the development of cardiovascular disease (CVD). Our aim was to reliably quantify the association of ADMA and its isomer symmetric dimethylarginine (S...

Descripción completa

Detalles Bibliográficos
Autores principales: Willeit, Peter, Freitag, Daniel F, Laukkanen, Jari A, Chowdhury, Susmita, Gobin, Reeta, Mayr, Manuel, Di Angelantonio, Emanuele, Chowdhury, Rajiv
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599532/
https://www.ncbi.nlm.nih.gov/pubmed/26021436
http://dx.doi.org/10.1161/JAHA.115.001833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599532/
https://www.ncbi.nlm.nih.gov/pubmed/26021436
http://dx.doi.org/10.1161/JAHA.115.001833

Ejemplares similares